Peripheral arterial disease (PAD) affects more than 200 million people worldwide, with its most severe manifestation, chronic limb-threatening ischemia, potentially leading to imminent limb loss in up to 11% of patients.
Frederick, MD – June 9, 2025: StageBio has announced plans to incorporate its capabilities and staff from its Jackson, VA location into its facility in Frederick, MD.
Date: June 22-25
Where: Chicago, IL
Stop by our booth #115!
Established by the merger of industry leaders, StageBio is an integrated partner serving the full spectrum of your histopathology needs. Our experienced team of laboratory staff, board-certified pathologists and archiving specialists are both experts in their respective fields and stewards of your projects’ success.
StageBio expands its capabilities on both sides of the Atlantic with the acquisition of TPL Path Labs.